Compare Indoco Remedies with Prime Securities - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs PRIME SECURITIES - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

PRIME SECURITIES 
   Change

Prime Securities is promoted by the Sheths which is also the controlling family of Great Eastern Shippng Company. The company offers financial services in the field of corporate finance, capital markets advisory, and broking. The company also establi... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES PRIME SECURITIES INDOCO REMEDIES/
PRIME SECURITIES
 
P/E (TTM) x 120.8 6.3 1,907.9% View Chart
P/BV x 2.0 10.8 18.9% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDOCO REMEDIES   PRIME SECURITIES
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
PRIME SECURITIES
Mar-18
INDOCO REMEDIES/
PRIME SECURITIES
5-Yr Chart
Click to enlarge
High Rs31763 507.0%   
Low Rs17831 582.0%   
Sales per share (Unadj.) Rs113.18.7 1,297.5%  
Earnings per share (Unadj.) Rs4.55.4 82.8%  
Cash flow per share (Unadj.) Rs11.85.5 216.8%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs73.23.8 1,919.5%  
Shares outstanding (eoy) m92.1526.52 347.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.25.3 41.0%   
Avg P/E ratio x55.58.6 642.0%  
P/CF ratio (eoy) x21.08.5 245.3%  
Price / Book Value ratio x3.412.2 27.7%  
Dividend payout %22.40-   
Avg Mkt Cap Rs m22,8301,236 1,847.4%   
No. of employees `0005.5NA 32,088.2%   
Total wages/salary Rs m2,20935 6,240.4%   
Avg. sales/employee Rs Th1,910.113,594.1 14.1%   
Avg. wages/employee Rs Th405.02,082.4 19.4%   
Avg. net profit/employee Rs Th75.58,414.7 0.9%   
INCOME DATA
Net Sales Rs m10,419231 4,508.6%  
Other income Rs m479 515.4%   
Total revenues Rs m10,466240 4,357.3%   
Gross profit Rs m1,349154 878.5%  
Depreciation Rs m6772 45,140.0%   
Interest Rs m2350 117,550.0%   
Profit before tax Rs m484161 300.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m011 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7228 254.5%   
Profit after tax Rs m412143 287.7%  
Gross profit margin %12.966.5 19.5%  
Effective tax rate %15.017.7 84.7%   
Net profit margin %4.061.9 6.4%  
BALANCE SHEET DATA
Current assets Rs m5,373120 4,462.5%   
Current liabilities Rs m4,15796 4,352.8%   
Net working cap to sales %11.710.8 108.3%  
Current ratio x1.31.3 102.5%  
Inventory Days Days680-  
Debtors Days Days7321 354.6%  
Net fixed assets Rs m6,24429 21,848.0%   
Share capital Rs m184133 138.6%   
"Free" reserves Rs m6,566-32 -20,659.3%   
Net worth Rs m6,750101 6,669.8%   
Long term debt Rs m1,2331 176,114.3%   
Total assets Rs m12,363217 5,702.3%  
Interest coverage x3.1806.0 0.4%   
Debt to equity ratio x0.20 2,640.5%  
Sales to assets ratio x0.81.1 79.1%   
Return on assets %5.266.1 7.9%  
Return on equity %6.1141.4 4.3%  
Return on capital %9.0168.5 5.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,1430-   
Net fx Rs m2,6190-   
CASH FLOW
From Operations Rs m1,22765 1,885.1%  
From Investments Rs m-1,3603 -41,215.2%  
From Financial Activity Rs m-388-87 446.1%  
Net Cashflow Rs m-521-19 2,814.1%  

Share Holding

Indian Promoters % 59.2 0.0 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.2 6,250.0%  
FIIs % 6.0 1.9 315.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 98.0 22.9%  
Shareholders   12,805 25,229 50.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   CENTURY PLYBOARDS  GEOJIT FINANCIAL SERVICES  CREST VENTURES  REDINGTON  NALWA SONS INV  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

PRIME SECURITIES Announces Quarterly Results (1QFY20); Net Profit Up 7.7% (Quarterly Result Update)

Aug 20, 2019 | Updated on Aug 20, 2019

For the quarter ended June 2019, PRIME SECURITIES has posted a net profit of Rs 30 m (up 7.7% YoY). Sales on the other hand came in at Rs 106 m (up 9.5% YoY). Read on for a complete analysis of PRIME SECURITIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

PRIME SECURITIES Announces Quarterly Results (4QFY19); Net Profit Up 66.1% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, PRIME SECURITIES has posted a net profit of Rs 49 m (up 66.1% YoY). Sales on the other hand came in at Rs 134 m (up 403.4% YoY). Read on for a complete analysis of PRIME SECURITIES's quarterly results.

PRIME SECURITIES 2017-18 Annual Report Analysis (Annual Result Update)

May 8, 2019 | Updated on May 8, 2019

Here's an analysis of the annual report of PRIME SECURITIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PRIME SECURITIES. Also includes updates on the valuation of PRIME SECURITIES.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Oct 22, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS